Serum reference interval of ARCHITECT alpha-fetoprotein in healthy Chinese Han adults: Sub-analysis of a prospective multi-center study

Clin Biochem. 2018 Feb:52:164-166. doi: 10.1016/j.clinbiochem.2017.11.002. Epub 2017 Nov 10.

Abstract

Objectives: Alpha-fetoprotein (AFP) has been widely used in clinical practice for decades. However, large-scale survey of serum reference interval for ARCHITECT AFP is still absent in Chinese population. This study aimed to measure serum AFP levels in healthy Chinese Han subjects, which is a sub-analysis of an ongoing prospective, cross-sectional, multi-center study (ClinicalTrials.gov Identifier: NCT03047603).

Methods: This analysis included a total of 530 participants (41.43±12.14years of age on average, 48.49% males), enrolled from 5 regional centers. Serum AFP level was measured by ARCHITECT immunoassay. Statistical analysis was performed using SAS 9.4 and R software.

Results: AFP distribution did not show significant correlation with age or sex. The overall median and interquartile range of AFP was 2.87 (2.09, 3.83) ng/mL. AFP level did not show a trend of increasing with age. The new reference interval was 2.0-7.07ng/mL (LOQ- 97.5th percentiles).

Conclusions: The reference interval for ARCHITECT AFP is updated with the data of adequate number of healthy Han adults. This new reference interval is more practical and applicable in Chinese adults.

Keywords: Alpha-fetoprotein; Hepatocellular carcinoma; Reference interval.

MeSH terms

  • Adult
  • Age Factors
  • Biomarkers, Tumor / blood
  • Carcinoma, Hepatocellular / blood
  • Carcinoma, Hepatocellular / diagnosis
  • China
  • Cross-Sectional Studies
  • Ethnicity
  • Female
  • Humans
  • Immunoassay / methods
  • Liver Neoplasms / blood
  • Liver Neoplasms / diagnosis
  • Male
  • Middle Aged
  • Prospective Studies
  • Reference Standards
  • Reference Values
  • Serum
  • Sex Factors
  • alpha-Fetoproteins / analysis*
  • alpha-Fetoproteins / standards*

Substances

  • Biomarkers, Tumor
  • alpha-Fetoproteins

Associated data

  • ClinicalTrials.gov/NCT03047603